Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study

Title:	Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study
Authors:	Sekmek, Serhat^{Aff1, IDs41598024813715_cor1}; Ozsan Çelebi, Sema Nur^Aff1; Bayram, Dogan^Aff1; Erol, Cihan^Aff1; Kos, Fahriye Tugba^Aff1; Sendur, Mehmet Ali Nahit^Aff1; Altıntas, Yunus Emre^Aff2; Tuylu, Tugba^Aff2; Yildirim, Sedat^Aff2; Biter, Sedat^Aff3; Kıdı, Mehmet Mutlu^Aff3; Bayram, Ertugrul^Aff3; Majidova, Nargiz^Aff4; Bayoglu, Ibrahim Vedat^Aff4; Atak, Mehmetcan^Aff5; Baskurt, Kadriye^Aff5; Akbas, Sinem^Aff6; Alkan, Ali^Aff7; Bayramgil, Ayberk^Aff8; Aslan, Ferit^Aff9; Sahin, Elif^Aff10; Balcik, Onur Yazdan^Aff11; Bayhan, Ahmet Ziya^Aff12; Saray, Seray^Aff13; Arpaci, Erkan^Aff14; Ergun, Yakup^Aff15
Source:	Scientific Reports. 14(1)
Database:	Springer Nature Journals